Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Stephen Damment
Introduction
Stephen Damment is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical science, particularly in the development of innovative solutions for treating brain tumors. With a total of two patents to his name, Damment's work exemplifies the intersection of creativity and scientific advancement.
Latest Patents
One of Stephen Damment's latest patents is the cyclodextrin-panobinostat adduct. This invention provides a method for producing a cyclodextrin-panobinostat adduct through a series of steps. The process begins with providing a first aqueous solution that includes a buffering agent, maintaining a pH in the range of 2.0 to 4.0. Next, panobinostat is dissolved in this solution to create a second aqueous solution. Finally, this second solution is mixed with a third aqueous solution containing cyclodextrin, resulting in a fourth aqueous solution that comprises the cyclodextrin-panobinostat adduct. This invention also includes an artificial cerebrospinal fluid (CSF) solution that incorporates the cyclodextrin-panobinostat adduct, highlighting its medical applications in treating brain tumors.
Career Highlights
Stephen Damment is currently associated with Midatech Limited, where he continues to innovate and develop new solutions in the medical field. His work has garnered attention for its potential impact on treatment methodologies.
Collaborations
Stephen collaborates with talented individuals such as Tom Coulter and Alessandro Pace, contributing to a dynamic and innovative work environment.
Conclusion
Stephen Damment's contributions to the field of medical science through his patents and collaborations reflect his commitment to innovation and improving healthcare solutions. His work continues to inspire advancements in the treatment of serious medical conditions.